INTEC PHARMA LTD JERUSALEM's ticker is and the CUSIP is M53644106. A total of 26 filers reported holding INTEC PHARMA LTD JERUSALEM in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $6,000 | -14.3% | 27,156 | 0.0% | 0.00% | – |
Q2 2020 | $7,000 | +40.0% | 27,156 | 0.0% | 0.00% | – |
Q1 2020 | $5,000 | -80.8% | 27,156 | -50.0% | 0.00% | – |
Q4 2019 | $26,000 | +36.8% | 54,312 | +100.0% | 0.00% | – |
Q3 2019 | $19,000 | -83.8% | 27,156 | 0.0% | 0.00% | – |
Q2 2019 | $117,000 | -7.9% | 27,156 | +56.6% | 0.00% | – |
Q1 2019 | $127,000 | -51.2% | 17,341 | -50.0% | 0.00% | – |
Q4 2018 | $260,000 | +168.0% | 34,682 | +100.0% | 0.00% | – |
Q3 2018 | $97,000 | +76.4% | 17,341 | +37.3% | 0.00% | – |
Q2 2018 | $55,000 | – | 12,631 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cormorant Asset Management, LP | 809,804 | $4,140,000 | 0.60% |
SABBY MANAGEMENT, LLC | 514,878 | $2,652,000 | 0.14% |
Migdal Insurance & Financial Holdings Ltd. | 497,200 | $2,542,000 | 0.06% |
Renaissance Technologies | 12,944 | $66,000 | 0.00% |
DEUTSCHE BANK AG\ | 12,724 | $65,000 | 0.00% |